Ovation Hiked Drug Price Almost 1,300 Percent: FTC
By Ben James ( December 16, 2008, 12:00 AM EST) -- Ovation Pharmaceuticals Inc. is "strongly disputing" the claims in a lawsuit the U.S. Federal Trade Commission filed Tuesday that accuses Ovation of jacking up the price for a drug used to treat a heart condition in premature infants after cornering the market in 2006....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.